Upgrade to SI Premium - Free Trial

Mizuho Securities Upgrades Amedisys (AMED) to Buy; Sell-Off Excessive

November 7, 2016 7:48 AM
Mizuho Securities upgraded Amedisys (NASDAQ: AMED) from Neutral to Buy with a price target of $47.00, calling the sell-off after ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Hot Upgrades Upgrades

Next Articles